Natalie Farris

Natalie Farris has a strong background in the pharmaceutical industry, with over 18 years of experience. Natalie'smost recent role was as Senior Director CMC at Atossa Therapeutics, Inc. where they managed contract manufacturing activities, reviewed cost proposals, and approved batch records and validation protocols. Prior to that, they held positions at GSK, Cerecor Inc., Vanda Pharmaceuticals, Eisai US, Shire, Chesapeake Biological Labs, AVI BioPharma, and Noramco, where they gained expertise in areas such as process development, analytical method development and validation, formulation development, and quality control. Natalie has demonstrated their ability to work well in team environments and has experience with various analytical instruments and troubleshooting.

Natalie Farris obtained their BS in Chemistry from the University of Delaware, where they studied from 1994 to 1999. Afterward, they pursued their Masters in Geochemistry at the same university, focusing on this field of study from 1999 to 2002.